In conversation with Adam Ford, Dr. Aubrey de Grey explains how recent extraordinary results with senolytic drugs suggest that the milestone of “Robust Mouse Rejuvenation” – a key step towards comprehensively undoing human aging – could be as little as three years away.
SciFuture Interview
- By SRF
- January 1, 2019
- 12:40 am
In conversation with Adam Ford, Dr. Aubrey de Grey explains how recent extraordinary results with senolytic drugs suggest that the milestone of “Robust Mouse Rejuvenation” – a key step towards comprehensively undoing human aging – could be as little as three years away.
- By SRF
- January 1, 2019
- 12:40 am
Recent Posts:
Sponsor a Student
SRF August 14, 2023 7:17 pm
Set My Heart Free: Two AmyloSENS Therapies Targeting Cardiac Amyloid in Clinical Trials
Michael Rae August 2, 2023 12:49 am
The Grand Opening of Our New Facilities
SRF July 9, 2023 3:42 pm
From Parachutes to Jetpacks: Clearing Brain Beta-Amyloid with Donanemab or Lecanemab Works, Though More Must be Done
Michael Rae June 5, 2023 6:56 pm
Lights, Camera, Action on AI-Powered Drug Discovery
SRF May 3, 2023 6:09 pm
Announcing the Biomarkers of Aging Consortium
SRF March 10, 2023 12:56 pm
Action at the Governmental Level for Longevity
SRF March 10, 2023 12:30 pm
Scenes from the Lab
SRF March 8, 2023 5:16 pm
A Busy Spring in the Education Department
SRF March 8, 2023 4:22 pm
New Peer-Reviewed Paper from SENS Research Foundation: Iron Homeostasis as a Senolytic Target
SRF February 8, 2023 5:47 pm
Announcement: Amicable Settlement of Donor Dispute
SRF October 28, 2022 3:34 pm